logo
Share SHARE
FONT-SIZE Plus   Neg

Simulations Plus Sees Q2 Revenues Of $2.8 Mln

Simulations Plus, Inc. (SLP), a provider of simulation software for pharmaceutical development, said Monday that it expects revenues of $2.8 million for the second quarter of fiscal 2012, up 6.4 percent from last year's revenue of $2.6 million.

The company said that approximately 15 percent of the revenues came from new software licenses and 4 percent from consulting studies.

Walt Woltosz, chief executive officer of Simulations Plus, said, "Fiscal year 2012 continues our trend of growth and profitability with a new record for any quarter in our second quarter, layering on top of our announced record first quarter revenue. We are focused on increasing our market penetration and delivering accelerating operating leverage as incremental top-line growth drives faster bottom-line increases."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Shares of Infineon Technologies AG were losing around 4 percent in German trading after the manufacturer of semiconductors and system solutions reduced its revenue growth forecast for fiscal 2016. This was despite a surge in second-quarter profit with strong revenues. For the third quarter, the company projects revenue growth sequentially. Halliburton Company (HAL) reported a loss from continuing operations of $2.4 billion, or $2.81 per share, in the first quarter of 2016, compared to a loss of $639 million or $0.75 per share, previous year. Halliburton recorded company-wide charges related primarily to asset impairments and severance... Pfizer Inc. (PFE) reported a profit for first-quarter 2016 that increased 27 percent from last year. Both earnings per share and revenue for the quarter beat analysts' expectations. The company raised its fiscal year 2016 guidance to reflect the strong operational performance.
comments powered by Disqus
Follow RTT